Anton Neschadim

Hon. UofT | Immunology, UofT | Ph.D., Medical Biophysics, UofT | MBA, Rotman

[ImmunoBiochem @ImmunoBiochem]

@ImmunoBiochem is pleased to announce a multi-target license and option agreement with @ImmunoGenInc to develop next-generation ADCs. https://t.co/nUxV0t3Ghe

[Lumira Ventures @LumiraVentures]

We are pleased to announce the closing of Lumira Ventures IV, oversubscribed at US$220 million, as well as the launch of a strategic venture fund in partnership with an international pharmaceutical company.

Read more: https://t.co/DcxRQpkAJ7

[Johnson & Johnson Innovation @JNJInnovation]

DYK: #JLABSToronto has supported 88 startup companies over the past 5 years!

Learn more about how our Canadian Johnson & Johnson Innovation - JLABS site has empowered innovators + created an impact on the Toronto healthcare ecosystem: https://t.co/au7lHWr3hl

[Donnelly Centre @DonnellyCentre]

#LTRI investigator & @uoftmedicine Prof. Daniel Drucker wins Gairdner International Award along with Profs. Joel Habener @harvardmed and Jens Holst @uni_copenhagen for research on glucagon-like peptides, via @globeandmail (paywall)
https://t.co/mJHkjytmzG

[Anton Neschadim @Neschadim]

Drs. Charpentier and Doudna get the Nobel Prize in Chemistry for CRISPR! #nobelprize #crispr https://t.co/rBdqWLMpGF

[Anton Neschadim @Neschadim]

Nobel Prize in Physics awarded for black hole formation as a prediction of general relatively and the supermassive compact object at the centre of our galaxy! #nobelprize https://t.co/w7ZumakRVb

[Anton Neschadim @Neschadim]

https://t.co/XeV30UCLqu https://t.co/VsNwXE9sO3

[Anton Neschadim @Neschadim]

Another great antibody conjugate deal! https://t.co/NszTjFZB2t

[Anton Neschadim @Neschadim]

https://t.co/rEwDyp46mK https://t.co/glH4K8OG37

[NCI Cancer Control @NCICancerCtrl]

Study Finds Nearly Everyone Who Recovers From COVID-19 Makes Coronavirus Antibodies https://t.co/1wupF4uyLX

[Anton Neschadim @Neschadim]

#interoperability #EHR https://t.co/IePg5ZwcKy

[Anton Neschadim @Neschadim]

Happy International Women’s Day!

[Anton Neschadim @Neschadim]

Two potentiated biologics now hold blockbuster potential! https://t.co/nxPbvmoXCy

[Anton Neschadim @Neschadim]

Great presentations and meetings at this year’s BIO CEO & Investor Forum!
#BIOCEO20

https://t.co/VOa39vNv9h https://t.co/bq8lwzDV14

[Science to Business Network (S2BN) @S2BNetwork]

#S2BNToronto - Curious what it takes to go from #scientist to #entrepreneur? Join us Wed, Feb 12, 6-9 pm. Learn about the #challenges from the founders/co-founders of Paradox Immunotherapeutics, ImmunoBiochem, and @MedMeHealth.

See more and register 👉 https://t.co/sLF5N1Rr1O

[Anton Neschadim @Neschadim]

Today is #WorldCancerDay!
At ImmunoBiochem Corporation, We are developing novel immunomodulatory molecules for oncology, and We want all cancer patients to have access to safe and efficacious therapies that would help beat their disease! https://t.co/H3415kBX9T

[Anton Neschadim @Neschadim]

Today is #WorldCancerDay!
At ImmunoBiochem Corporation, We are developing novel immunomodulatory molecules for oncology, and We want all cancer patients to have access to safe and efficacious therapies that would help beat their disease!

[Anton Neschadim @Neschadim]

Technologies to watch in 2020
https://t.co/TuZvOo0xgl

[MaRS @MaRSDD]

From March 30 - April 3, join Canada’s largest gathering of health startups, investors and partners at the 7th annual #HIW2020. Register before February 5 to save $200 on tickets.